Literature DB >> 11335898

Gastric carcinoma after surgical treatment of peptic ulcer: an analysis of morphologic features and a comparison with cancer in the nonoperated stomach.

W C MacDonald1, D A Owen.   

Abstract

BACKGROUND: Surgery for peptic ulcer is associated with an increased risk of later development of gastric carcinoma. This risk applies to cancer occurring in the distal stomach, not at the cardia. Mucosal alterations occurring in the nonneoplastic mucosa, adjacent to postgastrectomy carcinomas, are currently poorly defined.
METHODS: Between 1975 and 1995, the authors collected records of 76 patients with gastric carcinoma developing after previous ulcer surgery. Thirty-three gastrectomy specimens were available for study and were compared with a control series of gastric carcinomas occurring in the intact stomach. Morphologic features studied were macroscopic findings, tumor type, extent of inflammation, atrophy, intestinal metaplasia, reactive gastropathy, and presence of Helicobacter pylori. When possible, a semiquantitative grading system (Sydney system) was used.
RESULTS: The 33 patients with resected carcinoma after ulcer surgery were representative of the total 76 patients. There were no differences between the seven postulcer surgery cardia carcinomas and the control cardia carcinomas. The 18 distal carcinomas occurring after prior gastrectomy had significantly less intestinal metaplasia and Helicobacter pylori in the nonneoplastic mucosa than did the controls. Eight distal carcinomas occurring after a vagotomy and pyloroplasty had adjacent mucosa with findings intermediate between the gastrectomy carcinomas and the controls.
CONCLUSIONS: The differences shown suggest that for distally located postgastrectomy carcinomas Helicobacter pylori infection with extensive intestinal metaplasia may be relatively less important in pathogenesis and that intestinal reflux with reactive gastropathy more important. There was no evidence to support a different mechanism of pathogenesis for postsurgical carcinomas occurring at the cardia from that of control cardia carcinomas. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11335898     DOI: 10.1002/1097-0142(20010501)91:9<1732::aid-cncr1191>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Gastric pouch adenocarcinoma and tubular adenoma of the pylorus: a field effect of dysplasia following bariatric surgery.

Authors:  I Chebib; P L Beck; N G Church; S A C Medlicott
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

2.  Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats.

Authors:  Kjell K Ovrebø; Knut Svanes; Steinar Aase; Ketil Grong; Steinar Kvinnsland; Halfdan Sørbye
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 3.  The risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications.

Authors:  Zunwu Zhang
Journal:  J Gastrointest Cancer       Date:  2007

4.  Mini gastric bypass: Un-answered questions.

Authors:  Ramen Goel
Journal:  J Minim Access Surg       Date:  2017 Oct-Dec       Impact factor: 1.407

5.  Are objections to one anastomosis/mini gastric bypass scientific?

Authors:  Kamal K Mahawar
Journal:  J Minim Access Surg       Date:  2017 Oct-Dec       Impact factor: 1.407

6.  Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/one anastomosis gastric bypass.

Authors:  Sandeep Aggarwal; Amit Bhambri; Vitish Singla; Nihar Ranjan Dash; Atul Sharma
Journal:  J Minim Access Surg       Date:  2019-02-18       Impact factor: 1.407

7.  Influence of obesity and bariatric surgery on gastric cancer.

Authors:  Anna Carolina Batista Dantas; Marco Aurelio Santo; Roberto de Cleva; Rubens Antônio Aissar Sallum; Ivan Cecconello
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.